
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT
- About
ProShares UltraShort Health Care (RXD)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: RXD (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type ETF | Historic Profit -10.66% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) 10506 | Beta -1.2 | 52 Weeks Range 8.88 - 12.17 | Updated Date 04/2/2025 |
52 Weeks Range 8.88 - 12.17 | Updated Date 04/2/2025 |
Upturn AI SWOT
ProShares UltraShort Health Care
ETF Overview
Overview
ProShares UltraShort Health Care (RXD) seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index. It's a geared bearish bet on the health care sector.
Reputation and Reliability
ProShares is a well-known issuer of leveraged and inverse ETFs, with a solid track record for delivering on stated investment objectives.
Management Expertise
ProShares has a dedicated team with experience in managing complex investment strategies and leveraged ETFs.
Investment Objective
Goal
To deliver two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index.
Investment Approach and Strategy
Strategy: RXD utilizes a leveraged inverse strategy, employing derivatives such as swaps to achieve its -2x daily target.
Composition The ETF holds derivatives contracts linked to the Dow Jones U.S. Health Care Index, rather than directly owning healthcare stocks.
Market Position
Market Share: RXD's market share is small as this is a very niche ETF.
Total Net Assets (AUM): 34980719.53
Competitors
Key Competitors
- None - Unique niche
Competitive Landscape
RXD operates in a niche market with very few direct competitors due to its specific leveraged inverse strategy focused on the health care sector. Its advantage lies in providing a tool for investors seeking to profit from short-term declines in health care stocks. The main disadvantage is the high risk due to leverage and the potential for rapid value erosion in rising markets. Due to the -2x leverage effect, the decay of this fund is fast and it is not suitable for long-term investment.
Financial Performance
Historical Performance: Historical performance can vary significantly due to the leveraged and inverse nature of the fund. Past performance is not indicative of future results.
Benchmark Comparison: The ETF aims to deliver -2x the *daily* performance of the Dow Jones U.S. Health Care Index; tracking error is common for leveraged products over longer periods. Daily results should be compared to this index * -2.
Expense Ratio: 0.95
Liquidity
Average Trading Volume
The average daily trading volume is about 50,000 shares which indicates moderate liquidity.
Bid-Ask Spread
The typical bid-ask spread ranges between 0.10% and 0.20%, a moderate spread compared to the low average daily trading volume which affects liquidity.
Market Dynamics
Market Environment Factors
Performance is highly sensitive to news and events impacting the healthcare sector, including regulatory changes, drug approvals, and economic trends. A rising health care sector will rapidly diminish the value of RXD.
Growth Trajectory
RXD's growth potential is limited because it's designed for short-term tactical use, not long-term investing. Its strategy and holdings are consistently aimed at achieving its daily leveraged inverse target.
Moat and Competitive Advantages
Competitive Edge
RXD's competitive advantage lies in its specialized -2x leveraged inverse exposure to the health care sector, catering to sophisticated investors seeking short-term hedging or speculative opportunities. It provides a readily accessible tool for implementing bearish views on the healthcare market. ProShares' experience in managing leveraged ETFs also provides a degree of credibility. It may be appropriate for only very short term investors who have very specific bearish views on the Healthcare industry.
Risk Analysis
Volatility
RXD exhibits high volatility due to its leveraged nature and the inherent volatility of the health care sector.
Market Risk
RXD is subject to significant market risk, particularly related to fluctuations in the health care sector. Due to the -2x leverage effect, the decay of this fund is fast and it is not suitable for long-term investment.
Investor Profile
Ideal Investor Profile
RXD is suitable for sophisticated investors with a high-risk tolerance who have a short-term bearish outlook on the health care sector and understand the risks associated with leveraged and inverse ETFs.
Market Risk
RXD is best suited for active traders seeking short-term tactical opportunities, not long-term investors or passive index followers.
Summary
ProShares UltraShort Health Care (RXD) is a niche ETF designed for short-term trading, offering -2x leveraged inverse exposure to the Dow Jones U.S. Health Care Index. Its high volatility and complex structure make it suitable only for sophisticated investors with a bearish outlook on the healthcare sector. Due to the -2x leverage effect, the decay of this fund is fast and it is not suitable for long-term investment. Its performance is significantly affected by market events within the healthcare industry, and it carries substantial risks due to its leveraged nature.
Similar Companies
Sources and Disclaimers
Data Sources:
- ProShares website
- ETF.com
- Yahoo Finance
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Leveraged and inverse ETFs carry significant risks and may not be suitable for all investors.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ProShares UltraShort Health Care
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.